Rasayanika Biotechnologies India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -52.47%
- Profit Growth -204.65%
- Ebitda -170.56%
- Net Worth -6.78%
- Total Assets -98.83%
About Rasayanika Biotechnologies India
Rasayanika Biotechnologies India Private Limited (RBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 November 2013 and has a history of 11 years and two months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shekhar Suman, Ajit Kumar, and Preety Kumari serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100KA2013PTC071961
-
Company No.
071961
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Nov 2013
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Rasayanika Biotechnologies India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shekhar Suman
|
Director | 20-Nov-2013 | Current |
|
Ajit Kumar
|
Director | 20-Nov-2013 | Current |
|
Preety Kumari
|
Director | 01-Sep-2017 | Current |
Financial Performance of Rasayanika Biotechnologies India.
Rasayanika Biotechnologies India Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 52.47% decrease. The company also saw a substantial fall in profitability, with a 204.65% decrease in profit. The company's net worth dipped by a decrease of 6.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rasayanika Biotechnologies India?
In 2021, Rasayanika Biotechnologies India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Biotecnika Info Labs Private LimitedShekhar Suman and Ajit Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rasayanika Biotechnologies India?
Unlock and access historical data on people associated with Rasayanika Biotechnologies India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rasayanika Biotechnologies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rasayanika Biotechnologies India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.